Provided by Tiger Trade Technology Pte. Ltd.

Avalo Therapeutics Inc

19.27
-0.5600-2.82%
Post-market: 19.270.00000.00%16:41 EDT
Volume:759.04K
Turnover:14.70M
Market Cap:1.03B
PE:-4.37
High:19.86
Open:19.86
Low:18.88
Close:19.83
52wk High:24.27
52wk Low:8.65
Shares:53.63M
Float Shares:40.15M
Volume Ratio:0.95
T/O Rate:1.89%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.4100
EPS(LYR):-5.8400
ROE:-36.27%
ROA:-18.50%
PB:2.30
PE(LYR):-3.30

Loading ...

Avalo Therapeutics CFO Christopher Ryan Sullivan Disposes of Common Shares Worth $1.44 Million

Reuters
·
Aug 20

Is Avalo Therapeutics (AVTX) Cheap As Wider Q2 Losses Meet A Lower P B?

Simply Wall St.
·
Aug 19

Avalo Therapeutics CMO Mittie Doyle Disposes of 679 Common Shares Worth $13,580

Reuters
·
Aug 13

Avalo Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

CG Oncology Q2 Net Loss Widens on Higher R&D Costs

Reuters
·
Aug 06

Avalo Q2 2026 Earnings: $472.2 Million Supports 2027 Clinical Milestones

TradingKey
·
Aug 06

Avalo Therapeutics Posts Corporate Deck Spotlighting IL-1β Inhibitor Pipeline for Hidradenitis Suppurativa

Reuters
·
Aug 06

Avalo Q2 FY26 Net Loss Widens to $36.4 Million; R&D Expense Rises 66.1% to $23.4 Million

Reuters
·
Aug 06

Press Release: Avalo Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Updates

Dow Jones
·
Aug 06

Avalo Therapeutics Inc Expected to Post a Loss of 58 Cents a Share - Earnings Preview

Reuters
·
Aug 03

Avalo Therapeutics CMO Mittie Doyle Disposes of Common Shares Worth $20,000

Reuters
·
Jul 30

Avalo Therapeutics - Selling Stockholders May Sell up to 128,189 Shares of Common Stock - SEC Filing

THOMSON REUTERS
·
Jul 29

Avalo Therapeutics Says Some Shareholders May Sell Up to 128,189 Shares

MT Newswires Live
·
Jul 18

Avalo Therapeutics files to sell 128,189 shares of common stock for holders

TIPRANKS
·
Jul 18

What Avalo Therapeutics (AVTX)'s Russell Index Additions and Board Refresh Mean for Shareholders

Simply Wall St.
·
Jul 08

U.S. Stocks on the Move-core Natural Resources, Grabagun, Terawulf

Reuters
·
Jul 06

Leerink Starts Avalo at "outperform" on Skin Disease Drug Potential

Reuters
·
Jul 06

Avalo Therapeutics Inc : Leerink Partners Initiates Coverage with Outperform Rating; Target Price $38

THOMSON REUTERS
·
Jul 06

Avalo Therapeutics CMO Mittie Doyle Disposes of 4,654 Common Shares Valued at $93,080

Reuters
·
Jul 03

Avalo Therapeutics to Join the Russell 2000® and Russell 3000® Indexes

THOMSON REUTERS
·
Jun 26